Keyphrases
Algorithmic Schemes
50%
Anti-nucleocapsid
50%
Anti-nucleocapsid Antibodies
50%
Anti-spike
100%
Antibody Assay
50%
Antibody Targeting
100%
Antibody Test
50%
Clear Communication
50%
COVID-19
100%
IgG Antibody
50%
Patient Demographics
50%
Reporting Rate
50%
SARS-CoV-2 Antibodies
100%
Serological Test
50%
Specific Antigen
50%
Spike Protein
50%
Target Antigen
50%
Vaccination
50%
Vaccination Status
100%
Vaccine Development
100%
Medicine and Dentistry
Antigen Specificity
50%
Immunoassay
100%
Immunoglobulin G Antibody
50%
Infection
50%
Patient Population
50%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Vaccine Development
100%
Virus Nucleocapsid
100%
Immunology and Microbiology
Antigen Specificity
33%
Immunoassay
33%
Immunoglobulin G Antibody
33%
Monospecific Antibody
33%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Spike
100%
Vaccination Policy
100%
Vaccine Efficacy
66%
Virus Nucleocapsid
66%